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ABSTRACT 
Aims   We developed a new clinical integrated pathway linking a regional Ambulance Trust with a severe 
hypoglycaemia (SH) prevention team. We present clinical data from the first 2,000 emergency calls taken 
through this new clinical pathway in the East of England.  
Methods   SH patients attended by Ambulance crew receive written information on SH avoidance, and are 
contacted for further education through a new regional SH prevention team. All patients are contacted unless 
they actively decline.  
Results   Median age (IQR) was 67 (50 - 80) years, 23.6% of calls were for patients over 80 years old, and 
patients more than 90 years old were more common  than 20 - 25 year olds in this population. Most calls were 
for patients (84.9%) who were insulin treated, even those over 80 years (75%). One - third of patients attended 
after a call  were unconscious on attendance. 5.6% of patients in this call population had 3 or more ambulance 
call outs,  and they   generated 17.6% of all calls. In total, 728 episodes (36.4%) were repeat calls. Insulin 
related events were clinically more severe than oral hypoglycaemic related events.  Patients conveyed to 
hospitals (13.8%) were significantly older, with poorer  recovery in biochemical hypoglycaemia after ambulance 
crew attendance. Only 19 (1 %) opted out of further contact. Patients were contacted by the SH prevention team 
after a median 3 (0 - 6) days. The most common patient self - reported cause for their SH episode was related 
to percieved errors in insulin management (31.4%).   
Conclusions This new clinical service is simple, acceptable to patients, and a translatable model for prevention 
of recurrent SH in this largely elderly insulin treated SH population. 
  
Key words   Severe Hypoglycaemia    
    Ambulance   
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    Insulin     
    Emergency 
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1 INTRODUCTION. Severe hypoglycaemia (SH), defined as an episode severe enough to require 
external assistance in treatment and recovery, is a frequent and distressing experience for people with diabetes, 
and is due to insulin therapy or to some oral hypoglycaemics [1,2]. The significant direct and indirect costs 
related to ambulance attendance, hospital transfers and admissions, and lost productivity due to SH, are well 
described [2 – 4]. The impact of SH on quality of life, the fear of hypoglycaemia, and a determination to avoid 
SH often influences efforts to reach reasonable glycaemic targets [5, 6].  
More than 90% of the UK diabetes population have Type 2 diabetes, and recent large meta-analysis of   
hypoglycaemia outcomes in Type 2 diabetes [7], estimated that insulin treated Type 2 diabetes patients 
experience a mean of 1.05 (95% CI 0.0 – 3.69) SH episodes per annum.  The equivalent data for sulphonylurea 
treated patients and SH was 0.01 (95% CI 0 to 0.55). Elderly patients with insulin treated Type 2 diabetes and 
co-morbidities such as cognitive impairment, dementia, or renal impairment are more likely to experience SH [8 
-10], and have higher mortality and morbidity following SH [11, 12]. Robust glycaemic targets in diabetes 
management guidelines,  or in UK primary care diabetes quality frameworks, do not give enough weight to the 
risk of SH in the frail elderly, or promote clinically sensible targets relevant to the frail elderly [13, 14]. 
Ambulance Trusts are the main provider in the UK of first contact emergency medical services for people 
experiencing SH, and may be attending up to 100,000 emergency calls for SH episodes per annum [15]. 
Effective management of SH is one of the key performance indicators for UK Ambulance Trusts (16) and they 
operate effective  ‘see and treat’ policies for SH, where Ambulance Crew manage the episode at the scene, with 
few patients  carried onwards  to a local emergency department or admitted [17,18]. The  weakness of this 
model is  that SH patients  managed successfully by Ambulance Crew do not then receive any additional  
education triggered by the SH event, and the patient’s normal primary or secondary care diabetes team  often 
remain unaware of these episodes. In one large UK population more than half of ambulance attended SH 
patients either declined further treatment or were only advised to seek further advice at their discretion [18]. This 
is important, as many patients with SH make multiple calls about SH to emergency services, describe multiple 
previous SH episodes, and have had little advice or education on SH avoidance. The risk of further SH episodes 
can be reduced with enhanced diabetes education and support [1, 2, 8, 17 – 19]. Many patients are also 
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reluctant to identify themselves as having had an SH episode, as they understand the risk to then holding a 
driving licence [6].  
 We  developed a regional integrated SH management team for a population of 4.4 million in the East of 
England based around a single point of contact (SPOC) model between Ambulance Trust and primary and 
secondary care, with an associated mass SH education programme for patients and health care teams. We 
describe this model, and the first 2,000 SH episodes we have taken through this pathway.   
 
2 METHODS The East of England Ambulance Trust (EEAAT; www.eastamb.nhs.uk) provides emergency 
services to a population of 5.8 million in the East of England. The Ambulance service covers an area of 7,500 
square miles, supports 17 Acute Trusts and 19 primary care Clinical Commissioning Groups  (CCG) covering 
the counties of Norfolk, Suffolk, Cambridgeshire, Bedfordshire, Hertfordshire, and Essex. The Eastern 
Academic Health Science network (EAHSN; www.eahsn.org) is one of 15 academic health science networks 
in England, established by NHS England in 2013 to spread innovative services at scale and pace and connect 
academic and NHS organisations and local authorities to improve outcomes, and variance in outcomes, for 
patients. The EAHSN covers a population of 4.45 million within the EEAAT area, with an estimated 271,000 
people,  and an average adult diabetes prevalence of 6.1% [20] .  In 2014, before the current programme 
commenced, this Ambulance Trust recorded 9,374 emergency calls to people with a primary diagnosis of 
diabetes, overwhelmingly due to severe hypoglycaemia,  an estimated 80% being SH ; as elsewhere in the 
UK, there was no structured pathway to provide further care for these patients, or to identify causes of SH, or 
to link these recorded incidents with the patients existing primary or secondary care team. We developed a 
regional collaborative group of diabetes specialists from primary and secondary care, and secured significant 
funding from the EAHSN to develop a new pathway with the East of England Ambulance Trust to improve 
outcomes for SH patients. We developed a single point of contact model (SPOC) where Ambulance Crew 
attending an SH emergency, call through the patient details to the SPOC office after appropriate SH treatment. 
Attending Ambulance Crew also give every attended patient written information on SH avoidance, causes of 
SH and driving license implications (see supplementary material A and www.eahsn.org) ; the model we 
developed is an ‘opt out’ model , where patients with SH have to actively opt out of further contact from 
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educators by calling SPOC within 3 working days, and all patients are given this number. We then appointed 
and trained 12 part time clinical educators and project managers across the East of England, based in large 
Acute Trusts, to service this workload.  The patients details are called through to SPOC, and after 3 days 
these clinical details are passed to the relevant project managers in that area. These project managers or 
EAHSN educators then contact the patient to arrange further education and SH advice and support, given 
either directly in a one to one consultation, or by phone, or arranged through patients normal care team in 
primary or specialist care. In all areas, the intervention was standardised, but the method of delivery was 
adapted to local service models. We also undertook a mass education programme for all of  the  2,800 
Ambulance Crew in the EAHSN area, invited and arranged access for all 458 GP practices to online education 
on SH through the Cambridge Diabetes education programme (www.cdep.org ), and developed a model 
where all pharmacies in the East of England gave a standardised written leaflet on SH to patients collecting an  
insulin or oral hypoglycaemic prescription (see supplementary material B and www.eahsn.org).  
     This programme was not developed as a research programme, but as a new clinical service model in the 
East of England. The data in this paper are summary outcomes data from this clinical service, and all data 
analysis was undertaken on anonymised summary data, and analysis of routine clinical service data did not 
require research ethical approval. Patient clinical consent to refer to this new clinical service is gained by the 
crew at the time of referral , and patients can opt out of further clinical contact within 3 working days using a 
contact telephone number in the provided hypoglycaemia avoidance leaflet. Patient data is passed over a 
confidential and secure nhs.net pathway after 3 working days to the appropriate locality team for further 
contact. The data in this service was collected in real time prospectively after programme launch, with a  pre 
specified decision to analyse clinical outcome data from  the first consecutive 2,000 calls received through 
SPOC within the EAHSN area. 
   The EAHSN education programme has developed rapidly, and more than 50% of ambulance crew are now 
referring into this programme. However, during the development of this programme it would have been 
possible for a patient to have an Ambulance attended SH episode without referral to the programme, making 
accurate estimates of any overall population level  intervention effect difficult.   
    Patients attended by Ambulance crew were defined as unconscious (and analysed in this paper as 
unconscious)  by crew if they met the Joint Royal Colleges Ambulance Liaison Committee (JRCALC) criteria 
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derived from the Glasgow Coma Scale  for coma or impaired consciousness [21]. The JRCALC (21) guidelines 
are used by the EEAAT crew to determine the treatment pathway of SH, and the definition of SH, and for 
transferring the patient to an Acute Hospital.  These criteria [21] include transferring patients who have had a 
similar SH episode in the previous 48 hours, and patients who have not returned to a normal mental status 
within 10 minutes of intravenous glucose.  
   In this analysis, blood glucose data is derived from a capillary blood glucose test undertaken by Ambulance 
crew before treatment and after treatment as part of routine clinical care.  The after treatment blood glucose 
measurement  is taken by Ambulance crew at a  time that  depends on the intervention and speed of recovery, 
but JRCALC  guidelines [21] suggest reassessment after 10 minutes and  Ambulance crew would not normally 
leave a patient  at home unless capillary blood glucose  is recorded as > 5.0 mmol/L. Basic clinical data (such 
as medication use and self - reported previous SH episodes) are collected from the patient  by crew after 
recovery, although more detailed data (type of medication , duration of diabetes, or if patient had Type 1 or 
insulin treated Type 2 diabetes for example) are not collected in this acute situation. .Data is shown as mean 
(one standard deviation), or median and ( interquartile range). Comparisons between group variables were 
assessed by unpaired t test or Wilcoxon signed - rank test as appropriate.  
3 RESULTS 
3.1 Baseline data   (Table 1). The first 2,000 calls in the EAHSN area were generated between 1.12.14 and 
15.4.16 and referral activity into the programme is currently a mean of 62 per week across the East of England 
(March 2016). Of these 2,000 calls, only 19 (1%) declined further contact.  SH attended patients either self - 
identified themselves as being under the care of their GP for diabetes management (1131; 56.6%) or under a 
local secondary care team (769; 38.5%) or were unsure (100; 5.0%).   
The median age of this call population (n = 2,000) was 67 years (interquartile range IQR 50 - 80), with 472 calls 
(23.6%) from people over 80 years old; there were more callers aged > 90yrs (n = 77) vs than those aged 20 – 
25 years old. The overwhelming majority of these 2,000 calls were from people treated with insulin (1,697; 
84.9%), rather than with oral agents (251; 12.6%); a small number of calls (52; 2.6%) were from people with SH 
who were unaware if they were receiving oral hypoglycaemics.   
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Overall one - third of callers were unconscious, or had reduced consciousness,  on attendance, one - half had a 
glucose level < 2.5 mmol/L when attended by crew, and about one - half needed parenteral therapy 
(intramuscular glucagon or intravenous glucose). In addition, about one – third of callers described having had a 
similar SH episode in the previous month that needed third party assistance, including previous ambulance 
attendances in the previous month (Table 1)The Ambulance service was highly effective at treating these 2,000 
SH calls with only  276 (13.8%) requiring transfer to an Acute Hospital, and when the Ambulance Crew left the 
scene, nearly all subjects (1,933; 96.7%) had a capillary blood glucose (CBG)  measured by Ambulance crew of 
> 4 mmol/L, with median CBG of 6.4 mmol/L (5.4 – 8.1).       
3.2 Treatment category by age band (Table 2). Nearly all SH episodes in callers under 70 years old (n = 
1,094) were insulin treated (n = 997; 91.1 %), and even for callers over 80 years old (n = 472), most (n = 354; 
75%) were insulin treated (Table 2). The data collected by Ambulance Crew do not distinguish between those 
with Type 1 diabetes, with insulin treated Type 2 diabetes, or those receiving combined insulin and oral 
hypoglycaemics.      
3.3 Group differences by treatment category, age band, and transfer to Acute Hospital (Tables 3 - 5). The 
insulin treated SH callers (n = 1,697) had  significantly more severe clinical hypoglycaemia than the oral 
hypoglycaemic treated SH group, that is they were almost twice as likely to be unconscious on attendance, to 
need intramuscular glucagon, and have a significantly more severe biochemical hypoglycaemia (Table 3). 
Despite this, they responded to Ambulance crew treatment as well as those on oral hypoglycaemiv agents, and 
this younger group were then significantly less likely to be transferred to an Acute Hospital than the older group 
treated with oral agents (Table 3). The younger predominantly insulin treated group (under 70 years) were also 
significantly more likely to be unconscious on attendance and to have a more severe clinical and biochemical 
SH episode (Table 4).  Most of these calls were managed successfully by Ambulance crew at the scene, with 
only 276 (13.8 %) callers transferred by crew to an Acute Hospital for further treatment. The callers who were 
transferred to an Acute Hospital did not differ from  those not transferred in initial median blood glucose or 
frequency of glucose < 2.5 mmol/L (Table 5), but were significantly older, with higher rates of unconsciousness 
and glucagon requirements, and had responded less well to therapy at the scene in terms of hypoglycaemia 
recovery (Table 5).  
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3.4 Repeat callers and repeat SH (Tables 6 & 7).  
Of these 2,000 calls, 700 (35%) self - reported at the time of crew attendance that they had had a similar SH 
episode in the previous month. These subjects with a self - reported SH episode were significantly more likely to 
be insulin treated, to be unconscious and to have more severe hypoglycaemia when attended by Ambulance 
crew than those without any antecedent self - reported episode in the previous month. In addition, 372(18.6%) 
callers self - reported at the time of crew attendance that they had both a similar SH episode in the previous 
month, and  an ambulance call out in the previous month -  this group (Table 7) were particularly high risk with 
36.8 % unconscious on attendance and  60.8 % having a glucose on attendance of < 2.5 mmol/L.  These 2,000 
calls were generated by 1,546 individuals, of whom 1,272 (82.3%) made only one call. There were 728 calls 
(36.4%) made by 275 individuals (17.7%) who called more than once in this time period. In addition, 87 
individuals (5.6 %) made > 3 calls during this time period, and accounted for 352 of all calls (17.6%). 
 
3.5 Clinical education and contact with SH callers.   
All 2,000 SH calls led to contact by the education team, and 1442 (72.1%) then had direct face to face or  
telephone contact education on SH management and avoidance, largely delivered by the dedicated team of 
educators working in primary care. The median time between SPOC contact in the Ambulance Trust and the 
education team being made aware was 1 (0 – 4) days, between the team being informed and first contact with 
the caller was 3 days (0 – 6 days), and median time between SPOC referral and educational contact was 5  (1 - 
11) days.  
Of the 2,000 calls, 558 (27.9%) callers had no immediate direct contact by the education team, as they missed 
an initial education appointment (111; 5.6%), declined an appointment (36; 1.8%), had died (21; 1.2 %), were in 
hospital (8 ; 0.4%), or  were waiting  for an appointment (27 ; 1.4%). In addition, a further 238 (11.9%) did not 
respond to contact, although in all these subjects (and all those who missed appointments) the usual primary 
care  or specialist team were made aware of the SH episode and Ambulance contact, and the need for further 
clinical input.  
3.6 Crew, GP and Pharmacy education  
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There are an estimated 2,800 ambulance crew and paramedics in EAAAT (www.eastamb.nhs.uk). Between 
1.12.14 and 15.4.16, 1,214 (43.3%) of all crew  in the EAHSN area attended 6 large regional events, 35 
Ambulance station events,  or  received e - mail correspondence and materials on the pathway and relevant 
updates. These events were to highlight the causes, prevention and future care of SH patients, and to introduce 
the pathway. As of 15.4.16, 1200 (41%) crew had referred at least one SH patient.  Of the 458 GP practices in 
the EAHSN area, 174 practices had one staff member complete online training in SH management and 
avoidance. Lastly, all 742 community pharmacies in the EAHSN area have been given SH avoidance leaflets to 
distribute to all patients receiving an insulin or SH prescription and 75,000 of these leaflets have been printed.    
During education   sessions, we undertook a structured survey to collect the  views of participants on the causes 
of their SH episode. In total, 1051 patients, gave one or more  reasons (n = 1,771 total ) for the emergency 
Ambulance SH contact, the commonest being  insulin dose error or related to current insulin usage (556; 
31.4%), missed or delayed meals (297 ; 16.8%), intercurrent  illness (199; 11.2%), hypoglycaemia unawareness 
(189 ; 10.7%), or ‘too few carbohydrates’ (169 ; 9.5%). Exercise, excess alcohol, or problems with injection  
techniques each were each reported by approximately 5% of all patients.as causes of SH. 
   
4 DISCUSSION  
  
The clinical and health economic impacts of severe hypoglycaemia (SH) are well described [1, 2, 19]. In the 
UK, most emergency clinical contact for SH is managed by Ambulance crew attending after a 999 emergency 
call(16). However, there is  no  systematic whole system pathway in a large population for the further 
management of these ambulance attended SH patients that links ambulance crew with  primary care or 
specialist diabetes services, or which undertakes a mass education programme of SH patients and health care 
professionals. The current model provides an integrated service for a population of 4.4  million and a diabetes 
population of 271,000 based around a single point of contact (SPOC) model, with SH patients having to 
actively opt out of further contact, and with linkage to further education and support from the patients usual 
diabetes team, or from programme educators. An important element of this programme is that patients with a 
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SH episode were given 3 working days to opt out of further contact,  but  only 1% chose to, and the model of 
guaranteed further clinical contact after an SH event  is acceptable to the great majority of patients.  
 
 One of the most obvious features of this SH population is the age distribution, with 23.6 % of callers over 
80 years and 43.8 % over 70 years old. Other SH population studies have described similar age distributions 
in the UK and Europe [3,8,11, 22], but it is striking  that there are more people over 90 years old having SH 
events than 20 – 25 year olds in our population. The SH events in the elderly were largely associated with 
insulin use and this clearly raises questions about glycaemic targets and therapy in this older population. In the 
UK   general practices have operated under a performance management and reimbursement scheme called 
the Quality and Outcomes Framework (QOF) since 2004, with various achievement thresholds at a  practice 
level set at HbA1c targets of 59, 64, or 75 mmol/mol [23] . There is limited evidence of benefit for frail very 
elderly patients with diabetes managed within this framework  for these glycaemic targets, and a strong 
evidence base for immediate harm with robust glycaemic targets in this population [8 – 12, 14].  The very high 
risk of SH in elderly patients with multiple comorbidities, cognitive impairment, and high frailty scores in 
primary care is increasingly well recognised [24], along with a recognition of the need for more sensible 
tailored glycaemic targets in these patients [13,14].  
 In UK populations, ambulance attended and community based populations with SH have had a median 
plasma glucose of 2.3 (IQR 1.7 – 3.4) mmol/L (18), or 1.85 (IQR 0.72) mmol/L (11), which are broadly similar to 
the data in the current larger population. Ambulance Crew ‘see and treat’ policies appear to be an effective  
model for the treatment of an acute event, with the majority (96.7 %) in this series having a blood glucose of > 4 
mmol/L when crew departed, and a median blood glucose of 6.4mmol/L  . This model also appears to be 
effective at limiting the number of SH patients conveyed  onwards to local emergency departments. Only 13.8 % 
of Ambulance attended patients were conveyed  onwards, and this group were significantly older, more likely to 
be unconscious, and to live alone which suggest some of the clinical triggers for conveyance to further 
emergency care. The conveyed patients were not significantly different from those managed by crew alone 
interms of initial median blood glucose levels, but responded significantly less well to treatment when the 
decision was taken to transfer.  In the East of England, there was however a wide variance between clinical 
commissioning group (CGG) areas in rates of transfer (range 9 – 22%) to local Emergency Departments. This 
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may reflect geographical differences in skill mix among Ambulance crew, distance from local Emergency 
Departments (and therefore Ambulance turnaround times), and the views of Ambulance crew on pressures in 
local Emergency Depts. The conveyance rate to Emergency Department in this series (13.8 %) is relatively low 
in relation to the majority of  Ambulance attended European and UK SH populations, where transportation rates 
have been recorded as 21% [3], 27 % [17], and 35.3% [18], although closer to more recent UK populations at 7 
% (11). This low rate may be an underestimate, and may reflect a tendency  in Ambulance crew conveying 
patients to emergency hospital care not to pass patient details through to the SPOC pathway.  Recent analysis 
of hospital admissions for severe hypoglycaemia [25] in England based on Hospital Episode Statistics (HES) 
data suggested a decline in admission rates for SH between 2011 and 2014 adjusted for diabetes prevalence. 
Ambulance transport rates to emergency departments must be a key factor in admission rates, but it is unknown 
if the decline in SH admissions [26] reflects enhanced Ambulance crew performance and lower transport rates. 
The current data adds to literature on the safety of Ambulance crew provided ‘see and treat’ policies in the UK 
[16-18] with 96.7% of all attended episodes having a capillary blood glucose > 4mmol/l before crew left the 
patient.  
  About one - third of callers self - reported to crew that they had experienced a ‘similar severe episode in 
the previous month’ although not all of these episodes were managed by Ambulance crew. These self - 
reported recurring SH patients had significantly more severe hypoglycaemia clinically and biochemically, and 
were more likely to be insulin treated. As well as self - reported antecedent SH in the previous month, 36.4 % 
of the calls in this pathway were made by people who made multiple calls to ambulance crew, with a small 
minority generating a large number of calls (> 3  each) accounting for nearly 18% of all calls,  In other SH 
populations 31% [3], 37 % [11], or 12.7 % [18] of emergency SH ambulance contacts have been generated by 
repeat calls from the same patient(s), often relatively soon after the initial call, and up to 11% of patients have 
a further episode within 14 days [27]. These data suggest that while UK Ambulance Crew ‘see and treat’ 
policies are highly effective at treating individual SH  events, and at keeping patients at home following SH 
treatment, they are treating and identifying  a population with very high rates of recurrent SH events and 
repeat contact with emergency services. This is important, as simple modelling based on ambulance call out 
rates in the UK and the prevalence of SH calls, suggests there are between 48,400 and 98,736 SH Ambulance 
call outs per annum [15,27] in the UK, and the scale of this activity has been apparent for some time (15). If we 
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assume that perhaps one - third of these calls are from  repeat callers [3,11], then there are perhaps up to 
33,000 Ambulance SH calls per annum generated by repeat callers.  
 As far as we are aware, the programme we describe here is the first published large at scale attempt to 
link Ambulance SH events with enhanced structured education and support on SH avoidance from primary 
and secondary diabetes teams for all emergency SH patients,  linked to a mass patient  and healthcare 
education programme [28]. The majority of patients experiencing a SH episode attended by Ambulance Crew 
in the UK do not have evidence of further contact with primary or secondary care diabetes services [18,27] 
Many SH patients feel they have had only limited education in hypoglycaemia avoidance and management [1] 
and the lack of further education and support means patients do not have an opportunity to have an 
individualised glycaemic target reviewed (29), or access education and advice on hypoglycaemia   avoidance 
[1,2,29 – 31]. There may also be reluctance on the part of patients to let their normal diabetes team know 
about SH events, in case they feel clinical teams will be critical, or that it may effect holding a driving license 
[6]. Patients may under report SH episodes because of this risk, and people who under report in this way are 
more likely to have further SH episodes [6].   
 This programme covers a population of 4.4  million with an estimated 271,000 people with diabetes, and 
the total recurring salary and operational costs for the clinical  programme is an estimated £190,114 per  
annum for 9 hospitals  and  10 primary care clinical commissioning group areas. An upper cost for ‘see and 
treat’ SH in these data is £159, for an SH patient carried on to an Acute Hospital is reported at £314 (without 
admission), and health economic modelling of indirect costs of SH on lost productivity has been estimated at 
£60 per episode [32]. These estimates suggest a total tariff cost incurred by this activity (Table 1) of £359,722 
just with the first 2,000 cases in this pathway, of which £125,902 was generated by patients who made repeat 
calls. In 2014, the EEAAT made 9,374 attendances with ‘diabetes emergency’ as a primary cause of call in an 
area of 5.8 million, and adjusting for the smaller EAHSN population (4.4 million), and an estimated 80% of 
these calls being SH) suggests an estimated 5,753 SH call outs per annum in the EAHSN area, at an 
estimated tariff cost in total of £1.035 million per annum. To generate tariff savings to cover all the salary and 
operational costs of this network of educators and project managers would require a 20.3 % reduction in 
overall SH call rates. Further analysis of outcome data at a population level is required to demonstrate cost 
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efficacy. It should be noted that the current cost of this programme does not include modelling for the   costs 
and time of Ambulance crew and primary care staff to attend SH training. 
 There are weaknesses in the current analysis, which reflect the fact that this large regional programme 
only started on 1.1.15 , that different areas within the region entered the programme at different points early in 
2015, and that not all SH calls are yet referred into the pathway.  We estimate in the last year that we have 
contacted all Ambulance crew, that about one - half have attended face to face training days, and all relevant 
crew received the educational materials ,  and   are now actively referring. This would be concordant with 
current mean referral rates of 62 per week (projected 3,224 per annum), with an estimated potential maximum 
5,573 SH calls per annum and while referrals and referring teams are increasing,  this could clearly contribute 
to sample bias. In addition, it is possible that there is a bias in referral to the SPOC pathway, with less referral 
of those seen as ‘less severe’ in terms of social circumstances, treatment and SH severity by Ambulance crew, 
and that we are managing the ‘more severe’ or highest risk cases referred by Ambulance Crew. There are also 
some weaknesses in the education programme we offered. Firstly,, the education in SH prevention was largely 
directed at the patients, and in this frail elderly population a wider approach to include carers and family 
members might be more suitable. Secondly, the education programme for SH patients could perhaps have 
been stratified by risk of further SH, and  offered more intense support and follow up for those with 2 or more 
episodes. Lastly, we feel that current pressures on primary care staff may have limited uptake to the online 
education programme in SH avoidance that we offered.  
     
This paper describes the first year of  a new integrated SH pathway, and there remains significant work to be 
done on developing evidence of improved outcomes and sustainability  in terms of improved patient 
satisfaction, reduced SH risk, reduced SH impact on Ambulance call outs and Emergency Departments, and 
linkage with other diabetes process measures through NHS number and database linkage. However, the 
model   has strong patient acceptability with low opt out rates and effective management of SH is a UK 
Ambulance Trust priority (16). There is a need to undertake significant population level analysis of these data 
over the next few years to examine the impact of this programme on age and diabetes population adjusted SH 
rates in the intervention areas, and benchmark this against national SH data and   SH rates in areas without 
this model. This paper adds to the growing literature on the adverse impact of SH in a  largely elderly  insulin 
  
14 | P a g e  
 
treated diabetes population, highlights the high rate of repeat calls for SH episodes, and describes a new,  
effective, and translatable  model linking the emergency SH event attended by Ambulance crew, with an SH 
treatment and prevention team in a population of 4 million.   
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Table  1.   Clinical details for the first 2,000 severe hypoglycaemia (SH) episodes attended by 
Ambulance crew and managed through the integrated single point of contact (SPOC) 
pathway. 
 
    
  n       2,000     
  m:f       1129 : 871 
  Age (yrs)      67 (50 – 80) 
   > 70 years     876 (43.8%) 
   > 80 years     472 (23.6%) 
 
  Insulin treated  *     1697 (84.9%) 
  Oral hypoglycaemic treated **   251 (12.6%) 
  Diet alone          44 (2.2%)     
   ‘Not diabetes’           8 (0.4%) 
 
  Unconscious on attendance ***     645 (32.3 %) 
  Similar episode in previous month     700 (35.0%) 
  Lives alone        578 (28.9 %) 
  Under primary care management   1130 (56.5 %) 
  Transferred to Acute Hospital     276 (13.8 %) 
   
  Glucose level on attendance (mmol/L)  2.3 (1.9 – 2.9) 
  Glucose level < 2.5mmol/L on attendance  1117 (55.9%) 
  Treated with im glucagon or ivglucose  904 (45.2 %) 
  Treated with oral carbohydrate or oral glucose 1086 (54.3%) 
  Other treatment     7 (0.35%) 
  No treatment      3 (0.15%) 
  Glucose level after treatment (mmol/L)  6.4 (5.4 – 8.1) 
  Glucose level > 4 mmol/L after treatment **** 1933 (96.7%) 
 
        Data shown as n (%), or mean (one standard deviation) or median (interquartile range x - y) 
       *   Does not preclude concurrent oral hypoglycaemic therapy (in all Tables) 
       **    Oral hypoglycaemic therapy alone without insulin  (in all Tables) 
       ***   Patients unconscious, or with reduced level of consciousness (in all Tables) 
                ****   Data not available for n = 67 (3.3%) 
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Table 2   Treatment categories for 2,000 episodes of severe acute hypoglycaemia (SH) 
attended by Ambulance crew and managed through the integrated single point of contact 
(SPOC) pathway by age band.  
 
 
                 Age 
  
                        < 70 yrs          70 – 80 yrs           > 80 yrs  
  
 n         1094   434   472 
 
 Insulin     997(91.1 %)            346 (79.7%)  354 (75%)  
                                 
 Oral hypoglycaemics     70 (6.4%)  80 (18.4%)  101 (21.4%) 
 
 Diet         25 (2.3%)   8 (1.8%)    11 (2.3%)  
            
 Not known to have diabetes      2 (0.2%)    0 (0%)     6 (1.3%)  
 
       
    Data as n (%) for each age category 
    ‘No diabetes’ or ‘Diet’ recorded as patient response to Ambulance crew 
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Table  3. Clinical characteristics by treatment category for 2,000 severe acute hypoglycaemia 
episodes attended by Ambulance crew and managed through the integrated single point of 
contact (SPOC) pathway.  
 
 
         Oral hypoglycaemic        Insulin   
  
  n       303   1697     
 Age (yrs)      77 (65 – 85)  64 (48 -78)**    
 Unconscious on attendance    55 (18.2%)  590 (34.8%) **  
 Similar SH episode in previous month a  65 (21.5 %)   635 (37.4%) ** 
 Lives alone      117 (38.6 %)  461 (27.2%) **  
 Transferred to Acute Hospital   61 (20.1 %)  215 (12.7%) *   
  
 Glucose level on attendance (mmol/L)  2.6( 2.2 – 3.2 ) 2.3 (1.8 – 2.9) **   
 Glucose level < 2.5mmol/L on attendance  124 (40.9 %)  993 (58.5 %) **   
 Treated with im glucagon or iv glucose  89 (29.4%)  815 (48.0 %) **    
 Treated with oral carbohydrate or oral glucose 213 (70.3%)  873 (51.4 %) ** 
 Treated with other       1 (0.3%)  6 (0.4 %)   
 No Treatment      0 (0.0%)  3 (0.2%) 
 
 Glucose level after treatment (mmol/L)  6.1 (5.3 – 7.4)  6.4 (5.4 – 8.2) *    
 Glucose level > 4.0 mmol/L after treatment  292 (96.4%)  1641 (96.7 %)   
 
 
a
  Self described severe hypoglycaemic episode in previous month reported to Ambulance crew by 
patient  
Data shown as n (%), or   or median (interquartile range x - y). 
Oral hypoglycaemic group (n = 304) includes those self - identifying as ‘diet alone’ or those unaware of a 
diabetes diagnosis, on the assumption that documented SH was due to oral agents and patient was 
unclear about medication.  
 * p < 0.01  ** p < 0.0001 
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Table  4.  Clinical characteristics by age band for 2,000 severe acute hypoglycaemia episodes 
attended by Ambulance crew and managed through the integrated single point of contact 
(SPOC) pathway.  
 
      
        < 70 years   > 70 years   
  
  n       1124   876     
 Unconscious on attendance    437 (38.9%)  208 (23.7 %) ***   
 Similar SH episode in previous month  422 (37.5%)  278 (31.7%)*    
 Lives alone      265 (23.6%)  313 (35.7%) ***   
 Transferred to Acute Hospital   135 (12.0%)  141 (16.1%) *     
 Glucose level on attendance (mmol/L)  2.2 (1.8 – 2.9)  2.5 (2 – 2.9) ***    
 Glucose level < 2.5mmol/L on attendance  686 (61.0%)  431 (49.2%) ***    
 Treated with im glucagon or iv glucose  528 (47.0%)  376 (42.9%)    
 Treated with oral carbohydrate     591 (52.6%)  495 (56.5%)    
 Treated with other     3 (0.3%)  4 (0.5 %) 
 No Treatment      2 (0.2%)  1 (0.5 %) 
 
 Glucose level after treatment (mmol/L)  6.6 (5.4 – 8.4)  6.3 (5.4 – 7.7)*   
 Glucose level > 4.0 mmol/L after treatment  1086 (96.6 %)  847 (96.7%)   
 
   
 
 Data shown as n (%),   or median (interquartile range x - y) 
   
 * p < 0.05     *** p < 0.0001 
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Table  5.  Clinical characteristics of SH episodes managed by Ambulance Crew at scene, or conveyed 
to an Acute Hospital”  
 
 
 
 
 
            Not conveyed              Conveyed a  
  
  n       1724   276    
 Age (yrs)      66 (49 – 80)  72 (55 – 82) **    
 Unconscious on attendance    521 (30.2  %)  124 (44.9 %) ***   
 Similar SH episode in previous month  608 (35.3  %)  92 (33.3 %)    
 Lives alone      475 (27.6%)  103 (37.3 %) **    
 Insulin       1482 (85.9 %)  215 (77.9  %) **   
 Oral hypoglycaemic      198 (11.5 %)  53 (19.2 %) ***  
  
 Glucose level on attendance (mmol/L)  2.4 (1.9 – 2.9)  2.3 (1.8 – 2.8)   
 Glucose level < 2.5mmol/L on attendance  956 (55.5%)  161 (58.3 %)    
 Treated with im glucagon or iv glucose  750 (43.5 %)  154 (55.8 %) ***    
 Treated with oral carbohydrate or Oral Glucose 965 (56.0%)  121 (43.8%) ***   
 Treated with other     6 (0.4%)  1 (0.4%)  
 No Treatment      3 (0.2%)  0 (0.0%) 
   
 Glucose level after treatment (mmol/L)  6.4 (5.4 – 8.1)  5.9 (4.9 - 8) ***    
 Glucose level > 4.0 mmol/L after treatment  1689 (98.0 %)  244 (88.4%) *** 
 
 
 Data shown as n (%),   or median (interquartile range x - y) 
  
Oral hypoglycaemic group (n = 304) includes those self - identifying as ‘diet alone’ or those unaware of a 
diabetes diagnosis, on the assumption that documented SH was due to oral agents and patient was 
unclear about medication.  
 
 
a
   Please note these data for transferred patients are derived only from those whose details were 
referred  to the SPOC pathway.  
  
 * p < 0.05     ** p < 0.005   *** p < 0.0001 
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Table 6 Clinical and treatment characteristics of callers with, or without, self - reported severe 
hypoglycaemic (SH) episode in the previous month   
 
           No previous SH     Recurrent SH episode    
 
  
  n      1300     700 
 Age (yrs)     68 (50 – 80)    64 (49 – 79)    
 Unconscious on attendance   392 (30.2%)   253 (36.1  %)*    
 Lives alone     350 (26.9  %)   228 (32.6 %)*    
 Transferred to Acute Hospital  184 (14.2 %)   92 (13.1 %)     
 Insulin       1062 (81.7%)   635 (90.7 %) ***    
 Oral hypoglycaemic     193 (14.9%)   58 (8.3 %) ***    
 Glucose level on attendance (mmol/L) 2.40 (1.9 – 3.0)   2.30 (1.8 – 2.8) **   
 Glucose level < 2.5mmol/L on attendance 700 (53.9%)   417 (59.6%)     
 Treated with im glucagon or iv glucose 569 (43.8%)   335 (47.9 %)    
 Treated with oral carbohydrate     724 (55.7%)   362 (51.7 %)    
 Treated with other    5 (0.4 %)   2 (0.3 %)     
 No Treatment     2 (0.2%)   1 (0.1  %) 
 Glucose level after treatment (mmol/L) 6.40 (5.4 – 8)    6.50 (5.4 – 8.2)     
 Glucose level > 4.0 mmol/L after treatment 1261 (97%)   672 (96%)     
      
 Data shown as n (%),   or median (interquartile range x - y) 
   
 * p < 0.01    ** p < 0.005   *** p < 0.0001 
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Table  7  Clinical and treatment characteristics where callers self - reported no recent 
severe episode  or ambulance call out (A) in previous month, or a severe episode without 
a 999 call in the previous month (B), or with both a severe episode and an ambulance call 
(C) in the previous month 
   
       A    B   C 
  
n     1235   295   372   
Age (years)    68 (50 – 80)  64 (48 - 79)  64 (51 - 80)     
Unconscious on attendance   366 (29.64%)  104 (35.25 %)  137 (36.83%) *   
Lives alone     334 (27.04%)  89 (30.17%)  130 (34.95%)* 
Transferred to Acute Hospital  178 (14.41%)  41 (13.9%)  49 (13.17%)   
Insulin  treated    1012 (81.94 %) 272 (92.20%)  336 (90.32%) ** 
Oral Hypoglycaemic treatment  181 (14.66 %)  22 (7.46%)  33 (8.87 %) **  
 
Glucose on attendance (mmol/L)  2.40 (1.9 -3)  2.30 (1.8 – 2.9)  2.3 (1.8 – 2.7)*    
Glucose   < 2.5mmol/L  662 (53.6%)  175 (59.32%)  226 (60.75%)   
Treated with IM Glucagon    539 (43.64%)  133 (45.08%)  189  (50.81%)    
Treated with Oral Carbohydrates   689 (55.79%)  162 (54.92%)  180 (48.39%)* 
Treated with Other   5 (0.4%)  0 (0%)   2 (0.54%) 
No Treatment    2 (0.16%)  0 (0%)   1 (0.27%) 
 
Glucose after treatment (mmol/L)  6.4 (5.4 – 8.0)   6.4 (5.4 - 8.2)  6.7 (5.4 - 8.2) 
Glucose level > 4.0  mmol/L    1196 (96.84%) 287 (97.29%)  354 (95.16%) 
post treatment 
      
 
     By ANOVA across groups 
     *  p < 0,05  ** p < 0.001 
     Note: 98 patients did not report ambulance call out outcomes 
 
  
